Océanie · Bourse & Finance · Stockhead

Entropy starts 60-minute IV psilocin dosing in phase II binge-eating trial

Publié par Stockhead · Australie il y a 2 h

ENP says the first patient of its Cohort 2 Phase II BED trial was dosed with TRP-8803 on October 5 ... Read More The post Entropy starts 60-minute IV psilocin dosing in phase II…

Lire l'article complet sur Stockhead Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (stockhead.com.au)

Entropy starts 60-minute IV psilocin dosing in phase II binge-eating trial

À lire aussi

Is this cheap ASX dividend share one of the best income buys?

Alarming data shows rental tenants have hit breaking point

How Oliver Curtis gets hedged in the Firmus IPO

CSIRO-Moderna tie-up to strengthen biosecurity defences

ASX 200 Live Today - Wednesday, 7th October

How much should you spend as a wedding guest?

Entropy starts 60-minute IV psilocin dosing in phase II binge-eating trial

Partager

À lire aussi

Is this cheap ASX dividend share one of the best income buys?

Alarming data shows rental tenants have hit breaking point

How Oliver Curtis gets hedged in the Firmus IPO

CSIRO-Moderna tie-up to strengthen biosecurity defences

ASX 200 Live Today - Wednesday, 7th October

How much should you spend as a wedding guest?